Initially there was no specific way to reverse uh okay okay okay okay okay okay okay okay okay um like I mean I mean I mean okay okay okay okay okay okay okay okay okay the anticoagulant effect of dabigatran in the event of of of of of of of of of a like I mean like uh well I mean okay okay okay okay okay okay okay okay okay well major bleeding event, unlike for warfarin, but a dabigatran dabigatran dabigatran dabigatran dabigatran dabigatran dabigatran dabigatran dabigatran antidote (idarucizumab) was approved by the FDA in 2015.